Moestrup S K, Schousboe I, Jacobsen C, Leheste J R, Christensen E I, Willnow T E
Department of Medical Biochemistry, University of Aarhus, 8000 Aarhus C,
J Clin Invest. 1998 Sep 1;102(5):902-9. doi: 10.1172/JCI3772.
Screening of serum by using a surface plasmon resonance analysis assay identified beta2-glycoprotein-I/apolipoprotein H as a plasma component binding to the renal epithelial endocytic receptor megalin. A calcium-dependent megalin-mediated beta2-glycoprotein-I endocytosis was subsequently demonstrated by ligand blotting of rabbit renal cortex and uptake analysis in megalin-expressing cells. Immunohistochemical and immunoelectron microscopic examination of kidneys and the presence of high concentrations of beta2-glycoprotein-I in urine of mice with disrupted megalin gene established that megalin is the renal clearance receptor for beta2-glycoprotein-I. A significant increase in functional affinity for purified megalin was observed when beta2-glycoprotein-I was bound to the acidic phospholipids, phosphatidylserine and cardiolipin. The binding of beta2-glycoprotein-I and beta2-glycoprotein-I- phospholipid complexes to megalin was completely blocked by receptor-associated protein. In conclusion, we have demonstrated a novel receptor recognition feature of beta2-glycoprotein-I. In addition to explaining the high urinary excretion of beta2-glycoprotein-I in patients with renal tubule failure, the data provide molecular evidence for the suggested function of beta2-glycoprotein-I as a linking molecule mediating cellular recognition of phosphatidylserine-exposing particles.
利用表面等离子体共振分析检测法对血清进行筛查,结果表明β2-糖蛋白-I/载脂蛋白H是一种与肾上皮内吞受体巨蛋白结合的血浆成分。随后,通过兔肾皮质的配体印迹法和在表达巨蛋白的细胞中的摄取分析,证实了钙依赖性巨蛋白介导的β2-糖蛋白-I内吞作用。对肾脏进行免疫组织化学和免疫电子显微镜检查,以及对巨蛋白基因敲除小鼠尿液中高浓度β2-糖蛋白-I的检测,证实巨蛋白是β2-糖蛋白-I的肾脏清除受体。当β2-糖蛋白-I与酸性磷脂磷脂酰丝氨酸和心磷脂结合时,观察到其对纯化巨蛋白的功能亲和力显著增加。β2-糖蛋白-I和β2-糖蛋白-I-磷脂复合物与巨蛋白的结合被受体相关蛋白完全阻断。总之,我们证明了β2-糖蛋白-I具有一种新的受体识别特性。这些数据除了解释肾小管衰竭患者尿液中β2-糖蛋白-I的高排泄外,还为β2-糖蛋白-I作为介导暴露磷脂酰丝氨酸颗粒细胞识别的连接分子的假定功能提供了分子证据。